Correlation Between Surrozen and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Surrozen and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and C4 Therapeutics, you can compare the effects of market volatilities on Surrozen and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and C4 Therapeutics.
Diversification Opportunities for Surrozen and C4 Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Surrozen and CCCC is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Surrozen i.e., Surrozen and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Surrozen and C4 Therapeutics
Given the investment horizon of 90 days Surrozen is expected to generate 1.41 times more return on investment than C4 Therapeutics. However, Surrozen is 1.41 times more volatile than C4 Therapeutics. It trades about 0.06 of its potential returns per unit of risk. C4 Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 1,062 in Surrozen on September 3, 2024 and sell it today you would earn a total of 158.00 from holding Surrozen or generate 14.88% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Surrozen vs. C4 Therapeutics
Performance |
Timeline |
Surrozen |
C4 Therapeutics |
Surrozen and C4 Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Surrozen and C4 Therapeutics
The main advantage of trading using opposite Surrozen and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.Surrozen vs. Bolt Biotherapeutics | Surrozen vs. Larimar Therapeutics | Surrozen vs. Keros Therapeutics | Surrozen vs. Kezar Life Sciences |
C4 Therapeutics vs. DiaMedica Therapeutics | C4 Therapeutics vs. Lyra Therapeutics | C4 Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |